Appointments at Catalent, Novella and Publicis – People on the move

By Nick Taylor

- Last updated on GMT

Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Catalent, Novella and Publicis.

Catalent Pharma Solutions ​has made three appointments. Paul Wituschek​, formerly of Penn Pharmaceutical Services, has joined as vice president (VP) of sales for the development and clinical Services business unit.

Former Biogen Idec employee Sven Lee​ has been hired as VP of business development to lead the biologics team. Finally, Paul Ingram​ joins from Bilcare Global Clinical Supplies to fill the newly created role of European sales director for clinical supply services.

Doug Young​ has joined Publicis Touchpoint Solutions​, an outsourced message delivery business, as VP of the clinical centre-of-excellence. Young worked at Bristol-Myers Squibb for 16 years and also led a research team at Sandoz.

Novella Clinical ​has named Richard Farris​ as senior director for project management. Farris last worked as chief operations officer at Health Decisions. Novella has also promoted Michael Doyle​, formerly of OSI Pharmaceuticals, to global head of regulatory affairs.

And finally, former PPD CEO Fred Eshelman​ is to remain at the company in some capacity. in the short-term at least. Eshelman is due to retake the role of CEO on an interim basis in May.

We hear he’s not retiring​”, said Dave Windley, managing director, healthcare equity research at Jeffries & Company.​“That's not to say that he is reassuming the CEO title, but he is clearly haunting the offices of anyone so bold as to authorise discretionary spending​.”

Related topics Bio developments

Related news